II-6 · EXTERNAL COLLABORATION

External Collaboration

Academic · Clinical · Regulatory

The Kyoto Life Sciences Institute does not stand alone — it is one node within the academic networks of Japan and the world.

ACADEMIC NETWORK · 12 UNIVERSITIES

Academic Collaboration Network

Long‑term collaboration with twelve leading universities and research institutions across Japan, the Americas, and Europe — spanning biology, chemistry, pharmacy, and clinical medicine.

Japan

Kyoto University · Faculty of Medicine

Clinical Research / Stem Cells

Kyoto Prefectural University of Medicine

Gynecology Clinic / Endocrinology

Osaka University · Graduate School of Pharmaceutical Sciences

Transdermal Absorption Research

The University of Tokyo · Life Sciences

Microbiome Research

Keio University · School of Medicine

Regenerative Medicine

Hokkaido University · Department of Chemistry

Green Chemistry

Harvard Medical School

Clinical Translation · Women's Health

Stanford School of Medicine

Precision Medicine · Endocrinology

Europe

ETH Zürich

Biomaterials · Sustainable Chemistry

Karolinska Institutet

Stem Cells · Regenerative Medicine

Université Paris Cité

Dermatology · Microbiome

Oxford Nuffield Department of Medicine

Women's Endocrinology · Health

COLLABORATION FORMS

Joint Research Programs

The Group provides funding; universities contribute scientists and facilities.

Joint Laboratories

Four joint university laboratories within the Kyoto Institute.

Doctoral Co-Training

28 doctoral students sponsored to date.

Co-Authored Publications

48 peer-reviewed SCI papers within five years.

Academic Co-Hosting

Six conferences per year.

CLINICAL PARTNERSHIPS · 4 SOCIETIES

Clinical Collaboration

Japan Society of Obstetrics and Gynecology (JSOG, 1949)

Japan Society of Obstetrics and Gynecology

Seven of twelve clinical projects led by JSOG specialists
Coverage: Intimate health / Menopause management / Hormonal rhythm / Vaginal microecology
Three joint publications of the Women's Health White Paper

Japanese Dermatological Association (JDA, 1900)

Japanese Dermatological Association

Sensitive-skin clinical data collaboration
Joint formulation of sensitive-skin evaluation guidelines

Japanese Society for Regenerative Medicine (JSRM, 2001)

Japanese Society for Regenerative Medicine

Stem cell applications: ethics and clinical collaboration
Consensus on the boundary of regenerative medicine applied to beauty

Japanese Society of Anti-Aging Medicine (JAAM, 2003)

Japanese Society of Anti-Aging Medicine

Anti-aging research and clinical collaboration
Clinical validation of multi-peptide anti-aging

Ethics Review · All clinical projects pass IRB (Institutional Review Board) review and operate in collaboration with independent third-party ethics committees.

REGULATORY ENGAGEMENT · 4 AUTHORITIES

Regulatory Engagement

MHLW · Japan

Ministry of Health, Labour and Welfare

Quasi-drug (Iyakubugaihin) registration and review
GMP factory periodic inspections (twice yearly)
Participation in Japanese cosmetics regulation revisions

European Union

EU Cosmetic Regulation

CPNP compliance
31 SKUs registered

Food & Drug Administration

U.S. FDA

OTC drug registration (select products)
18 SKUs registered

Ministry of Food and Drug Safety

Korea MFDS

Cosmetics registration
23 SKUs registered

CROSS-GROUP EXCHANGE

Cross-Group Technology Exchange

Technology salons with other century-old Japanese enterprises · Six per year
Participation in IFSCC (International Federation of Societies of Cosmetic Chemists) conferences
Participation in international regenerative-medicine conferences
35 papers presented annually at academic conferences

The external collaborations listed on this page are limited to the academic and technical spheres. The Group's strategic investment portfolio (Toyo Bijin Capital) belongs to capital-side collaboration. For details, see /investment/portfolio.

Return to Science Vision →See Capital-Side Collaboration →See Women's Wellness Initiative →